LPL Financial
AUPH icon

LPL Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

LPL Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
72,614
+16,514
+29% +$264K ﹤0.01% 4232
2026
Q1 		$831K Sell
56,100
-8,426
-13% -$123K ﹤0.01% 4339
2025
Q4 		$1.03M Sell
64,526
-258,780
-80% -$3.67M ﹤0.01% 4050
2025
Q3 		$3.57M Buy
323,306
+262,295
+430% +$2.86M ﹤0.01% 2776
2025
Q2 		$517K Buy
61,011
+16,311
+36% +$131K ﹤0.01% 4362
2025
Q1 		$359K Sell
44,700
-1,900
-4% -$15.4K ﹤0.01% 4457
2024
Q4 		$418K Buy
46,600
+8,327
+22% +$67.9K ﹤0.01% 4248
2024
Q3 		$281K Buy
38,273
+2,091
+6% +$13K ﹤0.01% 4491
2024
Q2 		$207K Buy
36,182
+3,175
+10% +$16.7K ﹤0.01% 4545
2024
Q1 		$165K Sell
33,007
-210
-0.6% -$1.43K ﹤0.01% 4547
2023
Q4 		$299K Buy
33,217
+600
+2% +$4.94K ﹤0.01% 4090
2023
Q3 		$253K Buy
32,617
+2,900
+10% +$28.4K ﹤0.01% 4064
2023
Q2 		$288K Buy
29,717
+4,809
+19% +$49.9K ﹤0.01% 3885
2023
Q1 		$273K Sell
24,908
-431
-2% -$3.8K ﹤0.01% 3813
2022
Q4 		$109K Sell
25,339
-781
-3% -$4.53K ﹤0.01% 4144
2022
Q3 		$196K Sell
26,120
-423
-2% -$3.66K ﹤0.01% 3941
2022
Q2 		$267K Sell
26,543
-2,400
-8% -$26.8K ﹤0.01% 3724
2022
Q1 		$358K Buy
28,943
+3,060
+12% +$47.3K ﹤0.01% 3443
2021
Q4 		$592K Buy
25,883
+7,929
+44% +$188K ﹤0.01% 3129
2021
Q3 		$397K Sell
17,954
-4,036
-18% -$64K ﹤0.01% 3424
2021
Q2 		$285K Buy
21,990
+7,897
+56% +$101K ﹤0.01% 3625
2021
Q1 		$183K Buy
14,093
+1,190
+9% +$17.3K ﹤0.01% 3790
2020
Q4 		$178K Buy
+12,903
New +$188K ﹤0.01% 3561
2017
Q2 		– Sell
-30,002
Closed -$209K – 2805
2017
Q1 		$209K Buy
+30,002
New +$139K ﹤0.01% 2466

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's AUPH Position: Q2 2026 in Review

LPL Financial increased its Aurinia Pharmaceuticals (AUPH) stake by 29% in Q2 2026, buying an estimated $264K and bringing the position to 72,614 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4232.

LPL Financial first reported a position in AUPH in Q1 2017 and has held it in 24 quarters since. The position peaked at $3.57M in Q3 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • LPL Financial held 72,614 shares of Aurinia Pharmaceuticals worth $1.23M as of Q2 2026.
  • LPL Financial bought 16,514 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $264K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4232 holding.
  • LPL Financial first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 24 quarters since.
  • LPL Financial's Aurinia Pharmaceuticals position peaked at $3.57M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.